Mutual of America Capital Management’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.43M Sell
11,443
-290
-2% -$56.9K 0.02% 738
2026
Q1
$2.3M Sell
11,733
-244
-2% -$47.4K 0.03% 701
2025
Q4
$2.08M Sell
11,977
-172
-1% -$31.3K 0.02% 798
2025
Q3
$2.32M Sell
12,149
-678
-5% -$120K 0.02% 762
2025
Q2
$2.3M Sell
12,827
-110
-0.9% -$19.1K 0.02% 769
2025
Q1
$2.19M Sell
12,937
-463
-3% -$76.1K 0.03% 796
2024
Q4
$2.02M Sell
13,400
-339
-2% -$52.7K 0.02% 849
2024
Q3
$2.13M Sell
13,739
-301
-2% -$45K 0.02% 869
2024
Q2
$1.92M Sell
14,040
-547
-4% -$74.9K 0.02% 883
2024
Q1
$1.94M Sell
14,587
-498
-3% -$64.6K 0.02% 910
2023
Q4
$2.08M Sell
15,085
-661
-4% -$86.9K 0.02% 883
2023
Q3
$1.92M Sell
15,746
-405
-3% -$54K 0.02% 888
2023
Q2
$2.27M Buy
16,151
+225
+1% +$31K 0.03% 850
2023
Q1
$2.25M Sell
15,926
-386
-2% -$55.2K 0.03% 853
2022
Q4
$2.55M Buy
16,312
+130
+0.8% +$18.7K 0.03% 786
2022
Q3
$1.99M Buy
16,182
+142
+0.9% +$18.7K 0.03% 856
2022
Q2
$2.13M Buy
16,040
+128
+0.8% +$17.4K 0.03% 850
2022
Q1
$2.18M Sell
15,912
-317
-2% -$44.2K 0.02% 925
2021
Q4
$2.81M Buy
16,229
+157
+1% +$23.9K 0.03% 856
2021
Q3
$2.33M Sell
16,072
-997
-6% -$146K 0.02% 898
2021
Q2
$2.25M Sell
17,069
-204
-1% -$26.7K 0.02% 934
2021
Q1
$2.22M Buy
17,273
+335
+2% +$41.3K 0.02% 921
2020
Q4
$2.02M Sell
16,938
-5,123
-23% -$625K 0.02% 898
2020
Q3
$2.53M Sell
22,061
-824
-4% -$97.4K 0.03% 709
2020
Q2
$2.61M Buy
22,885
+4,540
+25% +$482K 0.04% 700
2020
Q1
$1.47M Buy
18,345
+256
+1% +$26.5K 0.02% 847
2019
Q4
$1.93M Buy
18,089
+45
+0.2% +$4.69K 0.02% 924
2019
Q3
$1.93M Buy
18,044
+57
+0.3% +$5.85K 0.03% 875
2019
Q2
$1.83M Buy
17,987
+129
+0.7% +$12.4K 0.03% 914
2019
Q1
$1.61M Sell
17,858
-64
-0.4% -$5.55K 0.02% 967
2018
Q4
$1.49M Buy
17,922
+255
+1% +$23.9K 0.02% 929
2018
Q3
$1.91M Buy
17,667
+193
+1% +$21.2K 0.03% 918
2018
Q2
$1.92M Buy
17,474
+82
+0.5% +$8.54K 0.03% 904
2018
Q1
$1.74M Sell
17,392
-134
-0.8% -$13.7K 0.03% 909
2017
Q4
$1.73M Buy
17,526
+277
+2% +$26.3K 0.03% 931
2017
Q3
$1.61M Buy
17,249
+528
+3% +$56.1K 0.03% 927
2017
Q2
$1.86M Sell
16,721
-21,021
-56% -$2.22M 0.03% 851
2017
Q1
$3.71M Sell
37,742
-809
-2% -$77.1K 0.07% 493
2016
Q4
$3.54M Buy
38,551
+6,067
+19% +$523K 0.07% 487
2016
Q3
$2.75M Buy
32,484
+15,931
+96% +$1.34M 0.06% 582
2016
Q2
$1.35M Sell
16,553
-924
-5% -$70.4K 0.03% 896
2016
Q1
$1.25M Buy
17,477
+1,621
+10% +$109K 0.03% 900
2015
Q4
$1.13M Sell
15,856
-179
-1% -$12K 0.03% 936
2015
Q3
$986K Buy
16,035
+236
+1% +$16.5K 0.02% 983
2015
Q2
$1.15M Sell
15,799
-101
-0.6% -$7.46K 0.03% 963
2015
Q1
$1.22M Buy
15,900
+262
+2% +$18.8K 0.03% 937
2014
Q4
$1.05M Buy
15,638
+204
+1% +$12.9K 0.02% 980
2014
Q3
$937K Buy
15,434
+203
+1% +$12.5K 0.02% 1003
2014
Q2
$894K Sell
15,231
-80
-0.5% -$4.68K 0.02% 1036
2014
Q1
$887K Sell
15,311
-789
-5% -$42.3K 0.02% 1018
2013
Q4
$862K Sell
16,100
-3,854
-19% -$229K 0.02% 1021
2013
Q3
$1.23M Buy
19,954
+27
+0.1% +$1.62K 0.03% 851
2013
Q2
$1.21M Buy
+19,927
New +$1.19M 0.04% 810

Other funds holding DGX

Mutual of America Capital Management's DGX Position: Q2 2026 in Review

Mutual of America Capital Management reduced its Quest Diagnostics (DGX) stake by 2.5% in Q2 2026, selling an estimated $56.9K and leaving 11,443 shares worth $2.43M. The position accounts for 0.02% of the portfolio, ranked #738.

Mutual of America Capital Management first reported a position in DGX in Q2 2013 and has held it in 53 quarters since. The position peaked at $3.71M in Q1 2017. 802 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Mutual of America Capital Management held 11,443 shares of Quest Diagnostics worth $2.43M as of Q2 2026.
  • Mutual of America Capital Management sold 290 Quest Diagnostics shares in Q2 2026, an estimated $56.9K.
  • Quest Diagnostics made up 0.02% of Mutual of America Capital Management's portfolio in Q2 2026, its #738 holding.
  • Mutual of America Capital Management first reported a position in Quest Diagnostics in Q2 2013 and has held it in 53 quarters since.
  • Mutual of America Capital Management's Quest Diagnostics position peaked at $3.71M in Q1 2017.
  • 802 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Mutual of America Capital Management's 13F filing for Q2 2026, filed 11 Aug 2026.